Potential biomarkers for detecting pulmonary arterial hypertension (PAH) in patients with systemic sclerosis. The elevation of the serum levels of endoglin and endothelin-1 could represent a useful tool as PAH biomarkers. Nevertheless, the diagnostic value of these markers needs to be determined by prospective studies. P. Coral-Alvarado. (SpringerLink) Rheumatology International 01/07/2009 (Also see: Pulmonary Hypertension)
This item was posted in the ISN Newsroom. Check the Newsroom every day for the latest scleroderma medical and support information.
Biomarkers for dectection of PAH in systemic sclerosis
No replies to this topic